Yes, IL-10 has therapeutic potential. It is being explored as a treatment for various inflammatory and autoimmune conditions. For instance, recombinant IL-10 has been tested in clinical trials for diseases like Crohn’s disease and rheumatoid arthritis. However, the balance between its anti-inflammatory and immunosuppressive effects must be carefully managed.
